Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy-Reference-Cited by-同舟云学术

Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapy

Published:2017-07-20 Issue:3 Volume:80 Page:583-589
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Bilen Mehmet Asim,Hess Kenneth R.,Subudhi Sumit K.,Aparicio Ana,Kim Jeri,Zurita-Saavedra Amado J.,Araujo John C.,Corn Paul G.,Stover Jessica,Lin Sue-Hwa,Logothetis Christopher J.,Tu Shi-Ming

Funder

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-017-3391-9/fulltext.html

Reference27 articles.

1. Kantoff PW, Higano CS, Shore ND et al (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363:411–422

2. Small EJ, Schellhammer PF, Higano CS et al (2006) Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol 24:3089–3094

3. http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm210012.htm

4. Sipuleucel-T: APC 8015, APC-8015, prostate cancer vaccine–Dendreon. Drugs R D 2006;7:197-201

5. Psaila B, Lyden D (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9:285–293

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy;Cancers;2023-11-13

2. Rapid aqueous synthesis of CuInS/ZnS quantum dots as sensor probe for alkaline phosphatase detection and targeted imaging in cancer cells;Talanta;2018-11

3. Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker;Future Oncology;2018-10

4. Therapeutic Vaccines for Genitourinary Malignancies;Vaccines;2018-08-12

5. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis;Cancer Management and Research;2018-08